Pineal peptides plus growth hormone secretagogues Growth hormone is primarily released during deep sleep, creating an interesting synergy with DSIP
It swaps in a dual GIP/GLP-1 agonist for the GLP-1 agonist semaglutide, and it has no dedicated combination trial, no fixed-dose product, and no regulatory review
It is not approved for, and makes no claim regarding, diagnosis, treatment, cure, or prevention of any disease
GHK-Cu start 1mg 3x weekly potentially advancing to daily 3mg
The bands were assessed by densitometry with Image J software (National Institutes of Health)
Delivery typically 13 business days